Flexibility and versatility, together with a dynamic and experienced team of researchers, are key ingredients for the success of the new CLEAR facility, exploring novel accelerator concepts at CERN.
Tessa Charles describes the impressive progress being made by synchrotron X-ray facilities to solve the structure of SARS-CoV-2 — a first step towards the development of drugs and vaccines.